Novartis Pharma Exits from Pakistan – Asrar Qureshi’s Blog Post 1183
Asrar Qureshi’s Blog Post 1183 discusses Novartis Pakistan’s transfer to International Investment II Limited (IIL), emphasizing its implications for the pharmaceutical sector. While the change aims to ensure supply continuity and local management agility, there are concerns about potential risks, including access to innovative medicines and workforce stability. The deal represents a significant shift in Pakistan’s pharmaceutical landscape.